Screener
aTyr Pharma ATYR PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses | 518 | 677 |
| Total current assets | 58,362 | 80,237 |
| Restricted cash | 1,495 | 2,235 |
| Property and equipment, net | 4,127 | 4,263 |
| Operating lease, right-of-use assets | 5,353 | 5,524 |
| Financing lease, right-of-use assets | 298 | 596 |
| Other assets | 190 | 148 |
| Total assets | $69,825 | $93,003 |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's PP&E (net)?
- aTyr Pharma (ATYR) reported PP&E (net) of $4.13M in Q2 2026.
- How has aTyr Pharma's PP&E (net) changed year-over-year?
- aTyr Pharma's PP&E (net) decreased by 8.8% year-over-year, from $4.53M to $4.13M.
- What is the long-term trend for aTyr Pharma's PP&E (net)?
- Over 5 years (2020 to 2025), aTyr Pharma's PP&E (net) has grown at a 36.5% compound annual growth rate (CAGR), from $899K to $4.26M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about aTyr Pharma's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude